Group One Trading’s Capricor Therapeutics CAPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $12.3M | Sell |
403,100
-336,400
| -45% | -$8.96M | 0.02% | 723 |
|
|
2025
Q4 | $21.3M | Buy |
739,500
+228,000
| +45% | +$2.98M | 0.04% | 509 |
|
|
2025
Q3 | $3.69M | Sell |
511,500
-23,600
| -4% | -$174K | 0.01% | 1761 |
|
|
2025
Q2 | $5.31M | Buy |
535,100
+296,700
| +124% | +$3.13M | 0.01% | 1285 |
|
|
2025
Q1 | $2.26M | Sell |
238,400
-178,300
| -43% | -$2.47M | 0.01% | 1714 |
|
|
2024
Q4 | $5.75M | Buy |
416,700
+151,900
| +57% | +$2.66M | 0.01% | 1067 |
|
|
2024
Q3 | $4.03M | Buy |
264,800
+212,500
| +406% | +$1.05M | 0.01% | 1165 |
|
|
2024
Q2 | $249K | Buy |
52,300
+9,100
| +21% | +$50.7K | ﹤0.01% | 3213 |
|
|
2024
Q1 | $293K | Sell |
43,200
-13,500
| -24% | -$65.3K | ﹤0.01% | 3228 |
|
|
2023
Q4 | $277K | Buy |
56,700
+54,500
| +2,477% | +$177K | ﹤0.01% | 3572 |
|
|
2023
Q3 | $7.52K | Sell |
2,200
-24,300
| -92% | -$137K | ﹤0.01% | 6506 |
|
|
2023
Q2 | $127K | Buy |
26,500
+10,600
| +67% | +$46.6K | ﹤0.01% | 4385 |
|
|
2023
Q1 | $67.1K | Sell |
15,900
-32,500
| -67% | -$140K | ﹤0.01% | 4629 |
|
|
2022
Q4 | $187K | Sell |
48,400
-18,300
| -27% | -$87.4K | ﹤0.01% | 3915 |
|
|
2022
Q3 | $400K | Buy |
66,700
+24,700
| +59% | +$126K | ﹤0.01% | 3456 |
|
|
2022
Q2 | $147K | Sell |
42,000
-8,600
| -17% | -$30.5K | ﹤0.01% | 4600 |
|
|
2022
Q1 | $174K | Buy |
50,600
+34,300
| +210% | +$135K | ﹤0.01% | 4945 |
|
|
2021
Q4 | $48K | Sell |
16,300
-40,900
| -72% | -$143K | ﹤0.01% | 6365 |
|
|
2021
Q3 | $230K | Buy |
57,200
+35,100
| +159% | +$160K | ﹤0.01% | 5020 |
|
|
2021
Q2 | $113K | Sell |
22,100
-24,800
| -53% | -$105K | ﹤0.01% | 5834 |
|
|
2021
Q1 | $219K | Sell |
46,900
-7,400
| -14% | -$42.6K | ﹤0.01% | 4936 |
|
|
2020
Q4 | $186K | Sell |
54,300
-4,700
| -8% | -$20.4K | ﹤0.01% | 4100 |
|
|
2020
Q3 | $310K | Buy |
59,000
+50,800
| +620% | +$296K | ﹤0.01% | 3293 |
|
|
2020
Q2 | $38K | Buy |
+8,200
| New | +$35.7K | ﹤0.01% | 4517 |
|
Other funds holding CAPR
SCM
TCM
VCM
RCM
JHC
